Literature DB >> 12378594

Quantitative examination of mechanophysical tumor cell enrichment in fine-needle aspiration specimens.

Linda M Ernst1, David L Rimm.   

Abstract

BACKGROUND: The advent of cDNA microarrays and other molecular technologies necessitates the acquisition of tumor cell-enriched material because nonmalignant cells often decrease the sensitivity of the assays. Fine-needle aspiration (FNA) specimens from carcinoma have long been noted to be enriched in malignant cells. The current study quantitated the relative representation of tumor versus nontumor cells in FNA specimens compared with tissue sections using breast carcinoma as a model.
METHODS: Five patients who had undergone both a diagnostic FNA and a surgical excision for breast carcinoma between January and July of 1996 were selected. Five random cellular fields from representative slides of the FNA (using the ThinPrep preparation of the wash) and surgical excision specimens were photographed digitally at x20 power. The cells were judged as tumor or nontumor cells and then were counted manually in each field.
RESULTS: The calculated percentage of malignant cells in the FNA specimen (as represented on the ThinPrep slide) ranged from 66-93% compared with the calculated percentage of 37-78% noted in histologic sections. The average of all 5 fields from all 5 cases showed that 83.1% of the total cells were malignant in the ThinPrep preparation compared with 62.3% in the histologic sections. This difference was highly statistically significant when analyzed using the chi-square test (P = 0.0009).
CONCLUSIONS: The percentage of malignant cells on FNA specimens from breast carcinoma, as assessed by ThinPrep, was found to be significantly higher than that obtained by surgical excision. The results of the current study quantitatively confirm the impression of practicing cytopathologists, but also suggest that FNA will provide a good substrate for cDNA microarray and other molecular analyses. Copyright 2002 American Cancer Society.

Entities:  

Mesh:

Year:  2002        PMID: 12378594     DOI: 10.1002/cncr.10746

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  CETSA-based target engagement of taxanes as biomarkers for efficacy and resistance.

Authors:  Anette Langebäck; Smaranda Bacanu; Henriette Laursen; Lisanne Mout; Takahiro Seki; Sigrun Erkens-Schulze; Anderson Daniel Ramos; Anna Berggren; Yihai Cao; Johan Hartman; Wytske van Weerden; Jonas Bergh; Pär Nordlund; Sara Lööf
Journal:  Sci Rep       Date:  2019-12-18       Impact factor: 4.379

2.  The effects of timing of fine needle aspiration biopsies on gene expression profiles in breast cancers.

Authors:  Vietty Wong; Dong-Yu Wang; Keisha Warren; Supriya Kulkarni; Scott Boerner; Susan Jane Done; Wey Liang Leong
Journal:  BMC Cancer       Date:  2008-09-30       Impact factor: 4.430

3.  Fine-Needle Aspiration-Based Patient-Derived Cancer Organoids.

Authors:  Anna E Vilgelm; Kensey Bergdorf; Melissa Wolf; Vijaya Bharti; Rebecca Shattuck-Brandt; Ashlyn Blevins; Caroline Jones; Courtney Phifer; Mason Lee; Cindy Lowe; Rachel Hongo; Kelli Boyd; James Netterville; Sarah Rohde; Kamran Idrees; Joshua A Bauer; David Westover; Bradley Reinfeld; Naira Baregamian; Ann Richmond; W Kimryn Rathmell; Ethan Lee; Oliver G McDonald; Vivian L Weiss
Journal:  iScience       Date:  2020-07-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.